New England Journal of Medicine · 2021 · 185 citations · 25 references
Once-daily relugolix combination therapy resulted in a significant reduction in menstrual bleeding, as compared with placebo, and preserved bone mineral density in women with uterine fibroids. (Funded by Myovant Sciences; LIBERTY 1 [L1] and LIBERTY 2 [L2] ClinicalTrials.gov numbers, NCT03049735 and NCT03103087, respectively.).
25
Menstrual Blood Loss–A Population Study
Leif Hallberg, Ann‐Marie Hôgdahl, Lennart Nilsson et al. · Acta Obstetricia Et Gynecologica Scandinavica · 1966 · 961 citations
Malcolm G. Munro, Hilary Critchley, Ian S. Fraser · International Journal of Gynecology & Obstetrics · 2018 · 910 citations · Full text